πŸ‡ΊπŸ‡Έ FDA
Patent

US 11845722

Deuterated compounds and uses thereof

granted A61KA61K31/47A61K45/06

Quick answer

US patent 11845722 (Deuterated compounds and uses thereof) held by Aldeyra Therapeutics, Inc. expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aldeyra Therapeutics, Inc.
Grant date
Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/47, A61K45/06, A61P, A61P17/00